CK-18, a hepatocyte intermediate filament protein released into the bloodstream during apoptosis, is widely recognized as a marker for nonalcoholic steatohepatitis (NASH) and MASLD severity [12]. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.